Your browser doesn't support javascript.
loading
Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
Miller, Brian J; Pikalov, Andrei; Siu, Cynthia O; Tocco, Michael; Tsai, Joyce; Harvey, Philip D; Newcomer, John W; Loebel, Antony.
Afiliação
  • Miller BJ; Department of Psychiatry and Health Behavior, Augusta University, Augusta, GA, United States of America. Electronic address: brmiller@augusta.edu.
  • Pikalov A; Sunovion Pharmaceuticals Inc., Marlborough, MA and Fort Lee, NJ, United States of America.
  • Siu CO; COS and Associates Ltd., Central, Hong Kong.
  • Tocco M; Sunovion Pharmaceuticals Inc., Marlborough, MA and Fort Lee, NJ, United States of America.
  • Tsai J; Sunovion Pharmaceuticals Inc., Marlborough, MA and Fort Lee, NJ, United States of America.
  • Harvey PD; University of Miami Miller School of Medicine, Miami, FL, United States of America.
  • Newcomer JW; Thriving Mind South Florida, Miami, FL, United States of America; Washington University School of Medicine, St. Louis, MO, United States of America.
  • Loebel A; Sunovion Pharmaceuticals Inc., Marlborough, MA and Fort Lee, NJ, United States of America.
Compr Psychiatry ; 102: 152195, 2020 10.
Article em En | MEDLINE | ID: mdl-32896775
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article